KOLOA, Hawaii — Intracranial pressure may be just as critical of a factor in the progression of glaucoma as IOP, according to a speaker here at Hawaiian Eye 2025.

Reducing systolic blood pressure to less than 120 mm Hg reduced cardiovascular event risk. ScienceDaily . Retrieved July 23, 2025 from www.sciencedaily.com / releases / 2023 / 11 / 231113192126.htm ...

Johns Hopkins Medicine researchers have published new research that reports on a potential alternative and less-invasive approach to measure intracranial pressure (ICP) in patients.

The timing of when a patient takes their blood pressure medication does not appear to matter for reducing CV event risk, according to two trials and a meta-analysis presented at the European ...

Mineralys Therapeutics’ aldosterone synthase inhibitor has chalked up a third clinical win in recent months, demonstrating once again its potential to reduce blood pressure in patients with ...

The earlier ACCORD trial compared an intensive blood-pressure treatment target with a standard blood-pressure treatment target in patients with type 2 diabetes and showed no significant difference ...